Skip to main content

In case you have not noticed, there have been some massive changes in the pharma services industry over the past six months: mergers, acquisitions, more mergers, venture capital/ private equity buy-outs, capital infusions, and even more mergers. What was not too long ago a group of top 10 CROs has quickly been cut to 6 with inVentiv purchasing i3 Pharma Services and PharmaNet and INC Research purchasing Kendle. So now what do we talk about as an industry? What do CROs do next? What does Pharma do about it?

View Resource